Company Information
USD
0.689
- (-0.1%)
NASDAQ:LXRX, LEXICON PHARMACEUTICALS, INC.
Industry: Biotechnology
End of Day: 8 May 2025 GMT-4
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drugs candidates are LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain; and sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for heart failure and type 1 diabetes.
Address
2445 Technology Forest Boulevard
11th Floor
Website
Classification
Sector
Healthcare
Industry Group
Biotechnology
Industry
Biotechnology
Key Executives
Ms. Diane Sullivan
Director
Dr. Alan J. Main,PhD
Executive VP, Divisional
Mr. Jeffrey L. Wade
CFO/President
Mr. Raymond Debbane
Chairman of the Board/Director
Dr. Samuel L. Barker,PhD
Director
Mr. Christopher J. Sobecki
Director
Mr. Philippe J. Amouyal
Director
Dr. Judith L. Swain,M.D.
Director
Dr. Robert J. Lefkowitz,M.D.
Director
Mr. Brian T. Crum
General Counsel/Senior VP
Mr. Lonnel Coats
CEO/Director
Ms. Kristen L. Alexander
Chief Accounting Officer/Vice President, Divisional
Dr. Craig B. Granowitz, M.D.,PhD
Chief Medical Officer/Senior VP
Dr. Kenneth B. Kassler-Taub, M.D.
Senior VP, Divisional
Dr. Kiernan A. Seth, PhD
Other Executive Officer/Vice President
Ms. Wendy E. McDermott
Vice President, Divisional
Ownership
Institution Holdings
Artal Group S A
117,553,284 (48.173%)
Artal International S.C.A.
117,553,284 (48.010%)
Bvf Inc
19,995,332 (8.194%)
BlackRock Inc
7,005,153 (2.871%)
Vanguard Group Inc
5,980,371 (2.451%)
BlackRock Fund Advisors
3,808,435 (1.561%)
Vanguard Investments Australia Ltd
3,702,774 (1.517%)
JPMorgan Chase & Co
3,043,291 (1.247%)
NEA Management Company, LLC
2,382,286 (0.976%)
Geode Capital Management, LLC
2,348,916 (0.963%)
Individual Holdings
Mr. Raymond Debbane
1,340,847 (0.548%)
Mr. Lonnel Coats
1,098,068 (0.450%)
Mr. Jeffrey L. Wade
324,214 (0.133%)
Dr. Alan J. Main,PhD
255,724 (0.105%)
Mr. Philippe J. Amouyal
240,332 (0.098%)
Mr. Christopher J. Sobecki
159,023 (0.084%)
Mr. Brian T. Crum
177,497 (0.073%)
Dr. Kenneth B. Kassler-Taub, M.D.
162,672 (0.067%)
Dr. Samuel L. Barker,PhD
79,617 (0.042%)
Dr. Kiernan A. Seth, PhD
53,136 (0.028%)
Funds Holdings
iShares Russell 2000 ETF
2,310,478 (0.947%)
Columbia Small Cap Value Fund I
1,237,245 (0.507%)
Fidelity Small Cap Index Fund
911,835 (0.374%)
State Street Russell Small/Mid Cap®
587,682 (0.241%)
VALIC Company I Small Cap Value Fund
517,596 (0.212%)
iShares Russell 2000 Value ETF
515,707 (0.211%)
Columbia VP Small Cap Value Fund
486,608 (0.199%)
iShares Russell 2000 Growth ETF
394,087 (0.161%)
BrighthouseI JPMorgan Small Cap Val Port
391,610 (0.160%)
BlackRock - Extended Mkt Fund CF
320,805 (0.131%)
Make Smart Investment Choices
GoodWhale Pte. Ltd.
1557 Keppel Road, #01-01
Singapore 089066
Singapore 089066
